Clinical trial Recruiting at 1 site Interventional Ages 25 to 65

Using deep brain stimulation to treat severe addiction

Official title: HABITS Study (Helping Addiction by Individualized Therapeutic Stimulation): Pilot Trial of Deep Brain Stimulation Guided By Stereoelectroencephalography for Treatment-Refractory Substance Use Disorders

Run by Centre for Addiction and Mental Health · NCT06973512 · Data updated 2026-11-12

This study is testing if deep brain stimulation can help people with severe addiction who haven't found success with other treatments.

Quick facts

Study typeInterventional
Ages25 Years to 65 Years
SexAll
Enrollment10 (estimated)
SponsorCentre for Addiction and Mental Health
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedJanuary 1, 2028
Study endsJanuary 1, 2028
Registry record updatedApril 29, 2026
Trial IDNCT06973512 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 25-65 with severe substance use disorders who have not responded to at least two evidence-based treatment modalities.

Probably not a fit

Patients with major medical co-morbidities or contraindications to neurosurgical interventions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The HABITS Study aims to explore the effectiveness of deep brain stimulation (DBS) for individuals suffering from treatment-refractory substance use disorders (SUD). This innovative approach utilizes stereoelectroencephalography (SEEG) to personalize the stimulation targets and settings for each patient, addressing the unique neural networks involved in addiction. By combining DBS with a comprehensive drug craving provocation paradigm and advanced AI analysis, the study seeks to improve treatment outcomes for those who have not responded to traditional therapies. The study is designed to be minimally invasive and reversible, with a focus on enhancing the precision of treatment.

Why it matters

Potential benefit: If successful, this study could provide a new, effective treatment option for individuals struggling with severe substance use disorders.

How similar studies have gone: Other studies have shown promise for deep brain stimulation in treating various conditions, but this specific application for substance use disorders is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult, Age 25-65
* Severe DSM-5 substance use disorder (SUD) as assessed by Structured Clinical Interview for DSM-5 (SCID-5)
* Treatment refractory as evidenced by non-response to an adequate trial of ≥2 evidence-based treatment modalities for their substance use disorder in the most recent 3 years of illness, as determined by the study clinical team
* Able to comply with study visit schedule and timeline
* Stable housing and reliable transportation
* Treatment-seeking (\>7 on a 0-10 readiness ruler and open to the end-of-treatment outcome of abstinence)
* Capable of understanding and providing informed consent

Exclusion Criteria:

* Contraindications to neurosurgical interventions such as major medical co-morbidities, including uncontrolled hypertension, coagulopathy, severe diabetes, major organ system failure, active infection or history of implant-related infections, immunocompromised state, or malignancy with \<5 years life expectancy
* Contraindications for MRI, including implanted metallic devices (e.g., non-MRI-safe cardiac pacemaker or neurostimulator; some artificial joints metal pins; surgical clips; or other implanted metal parts), or claustrophobia or discomfort in confined spaces
* Cardiac pacemaker/defibrillator, or other implanted stimulator
* Presence of epilepsy, stroke, or degenerative disorder of the nervous system
* Serious problems with literacy, vision, or hearing

Where it's running

  • Centre for Addiction and Mental Health / Toronto Western Hospital
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.